Currently, Aimost needs to be used in quiet indoor settings, with your smartphone's microphone placed directly against the skin for optimal accuracy.

Note: By 2025, we're upgrading the system to work accurately even with background noise and through thin clothing.

Generally, smartphones released since 2022 work well with Aimost without significant accuracy issues.

Note: While recording quality may vary slightly depending on your device's microphone and settings, we're continuously improving compatibility to ensure reliable performance across both new and older devices.

Absolutely! Adults and seniors can use Aimost with the same level of accuracy as younger users. While children's sounds tend to be louder and easier to detect, the characteristics of abnormal sounds remain consistent across all ages, so our AI maintains reliable accuracy regardless of age.

Note: We're currently validating our technology with elderly participants through partnerships with the Seoul Business Agency and Guro-gu Senior Citizen Centers, and we're expanding collaborations with aging communities to ensure continued accuracy for all age groups.

No. Just as age doesn't affect accuracy, abnormal biological sound patterns are universal across all human populations. Our AI analyzes these common features, ensuring consistent performance regardless of ethnic background.

Note: We're also working with global medical groups and telemedicine partners to build diverse training datasets, guaranteeing accuracy across all populations worldwide.

Our biggest advantage is simplicity—Aimost works with just your smartphone, no expensive additional equipment needed. By 2026, it will operate completely offline for maximum convenience.

What really sets us apart is our development partnership with Korea's leading pediatric hospital, Our Children's Hospital. This physician-driven approach ensures we have access to large-scale, sustainable medical data that creates a significant competitive advantage.

Our vision is to make Aimost as common in households as thermometers and blood pressure monitors—providing the first line of disease screening and reliable guidance for when to seek emergency care.

Yes, our accuracy has been verified by accredited institutions both in Korea and internationally. We're targeting MFDS Class II medical device certification by February 2026 to ensure the highest standards of reliability and safety.

Built on 260,000 medical data samples with continuous improvement through ongoing data collection, Aimost becomes more accurate over time. We track not just accuracy but also sensitivity and specificity using ICBHI scores to minimize missed cases.

Important: Like any medical screening tool, Aimost cannot be 100% perfect. If symptoms persist despite a "normal" result, we strongly recommend consulting with healthcare professionals.

No, Aimost doesn't diagnose specific diseases. Instead, it detects warning signs of serious conditions to help people who need urgent care seek help quickly.

The abnormal respiratory and cardiac sounds it identifies can indicate both congenital and acquired serious conditions. Early detection helps prevent disease progression, making Aimost a valuable everyday health monitoring tool.

We're currently conducting clinical validation in hospitals and plan to launch official services in the first half of 2026, once certification is complete.

The service will begin with AI screening for lung diseases through abnormal respiratory sound detection, followed by cardiac disease screening through abnormal heart sound detection later in 2026.

Looking ahead, we plan to expand into AI-powered image and video analysis using smartphone cameras, enabling broader health condition coverage.